Viewing Study NCT06144918


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2025-12-26 @ 3:56 AM
Study NCT ID: NCT06144918
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2023-11-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure
Sponsor: Skye Bioscience, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module